electroCore, Inc.
NASDAQ:ECOR
electroCore, Inc.
Net Change in Cash
electroCore, Inc.
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
electroCore, Inc.
NASDAQ:ECOR
|
Net Change in Cash
-$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Change in Cash
-$421m
|
CAGR 3-Years
33%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Change in Cash
$1.5B
|
CAGR 3-Years
106%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
Stryker Corp
NYSE:SYK
|
Net Change in Cash
$681m
|
CAGR 3-Years
780%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Net Change in Cash
$720m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
114%
|
CAGR 10-Years
2%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Change in Cash
-$1.2B
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-21%
|
|
electroCore, Inc.
Glance View
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 52 full-time employees. The company went IPO on 2018-06-22. nVNS is a platform for bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The firm is providing gammaCore device for the treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults. gammaCore permits patients to self-administer doses of nVNS on an as-needed basis for treatment of prevent multiple types of headache pain via the vagus nerve. The gammaCore therapy is also used to treat primary headache, including migraine, cluster headache (CH), hemicrania continua and paroxysmal hemicrania (PH) and coronavirus (COVID-19).
See Also
What is electroCore, Inc.'s Net Change in Cash?
Net Change in Cash
-6.9m
USD
Based on the financial report for Dec 31, 2024, electroCore, Inc.'s Net Change in Cash amounts to -6.9m USD.
What is electroCore, Inc.'s Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
7%
Over the last year, the Net Change in Cash growth was 7%.
You don't have any saved screeners yet